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Cells entering mitosis become rounded, lose attach-
ment to the substrate, and increase their cortical
rigidity. Pivotal to these events is the dismantling of
focal adhesions (FAs). How mitotic reshaping is
linked to commitment to divide is unclear. Here, we
show that DEPDC1B, a protein that accumulates in
G2, coordinates de-adhesion events and cell-cycle
progression at mitosis. DEPDC1B functions as an
inhibitor of a RhoA-based signaling complex, which
assembles on the FA-associated protein tyrosine
phosphatase, receptor type, F (PTPRF) andmediates
the integrity of FAs. By competing with RhoA for
the interaction with PTPRF, DEPDC1B promotes the
dismantling of FAs, which is necessary for the
morphological changes preceding mitosis. The cir-
cuitry is relevant in whole organisms, as shown by
the control exerted by the DEPDC1B/RhoA/PTPRF
axis on mitotic dynamics during zebrafish develop-
ment. Our results uncover an adhesion-dependent
signaling mechanism that coordinates adhesion
events with the control of cell-cycle progression.
INTRODUCTION
The cell cycle is a sequence of coordinated events leading to
genome duplication and its correct segregation into the daughter
cells at mitosis. The fidelity of this process is secured by mech-
anisms that are activated at specific restriction points: the
cellular checkpoints (Ge´rard and Goldbeter, 2009; Hartwell and
Weinert, 1989; Tyson and Novak, 2008). The G2/M checkpoint
occurs at the onset of mitosis and is in charge of preserving
genomic integrity and its inheritance without damage or muta-
tions (Branzei and Foiani, 2008; Lo¨brich and Jeggo, 2007). The
G2/M transition is driven by several mitotic kinases, including
the Aurora, Polo, and the cyclin-dependent kinases (CDKs) (Ho-
chegger et al., 2008; Lindqvist et al., 2009; Smits and Medema,
2001). The activation of the CDK1/cyclin B complex (mitosis-420 Developmental Cell 31, 420–433, November 24, 2014 ª2014 Thepromoting factor [MPF]) is key in the control of mitotic entry
and depends onmultiple mechanisms that modulate the expres-
sion and/or localization of cyclin B and the phosphorylation sta-
tus of CDK1 (Gavet and Pines, 2010; Lindqvist et al., 2009; Nigg,
2001; Norbury et al., 1991; Santos et al., 2012). Once activated,
theMPF phosphorylates a series ofmolecular targets that trigger
downstream mitotic events, such as nuclear envelope break-
down and chromosome condensation (Nigg, 2001; Ohi and
Gould, 1999).
At mitotic entry, cells also become rounded, lose attachments
to the substrate, and display increased cortical rigidity (Cramer
and Mitchison, 1997; Kunda and Baum, 2009; The´ry and Bor-
nens, 2006). This reshaping is thought to be necessary to set
the axes for symmetric or asymmetric partitioning of cell deter-
minants and to establish a correct spindle orientation (Kunda
and Baum, 2009; The´ry et al., 2005).
Adhesion to the extracellular matrix (ECM) is mainly mediated
by structures called focal adhesions (FAs), in which establish-
ment, maturation, and dismantling are tightly controlled (Parsons
et al., 2010; Zamir and Geiger, 2001). FAs exert a mechanostruc-
tural role by physically connecting the actin cytoskeleton to ECM
via integrin receptors, and a signaling role, serving as hubs to
assemble signaling complexes (Mitra and Schlaepfer, 2006; Par-
sons et al., 2010). As cells approach mitosis, they dismantle FAs
via inactivation of FA kinase (FAK) and downmodulation of Rap1-
GTPase activity (Dao et al., 2009; Kunda and Baum, 2009; Puga-
cheva et al., 2006; Yamakita et al., 1999). Concomitantly, cells
experience mitotic rounding and cortical stiffening caused by
actomyosin remodeling through RhoA (Maddox and Burridge,
2003; Matthews et al., 2012), ezrin, radixin, and moesin complex
(ERM) proteins (Carreno et al., 2008), andmyosin II (Maddox and
Burridge, 2003).
Amechanistic picture of how the cell coordinates detachment/
rounding and entry into mitosis is, however, still lacking. Here we
show that DEPDC1B, a cell-cycle-regulated gene (Nicassio
et al., 2005), mediates the interplay between cell-cycle progres-
sion and de-adhesion events at the mitotic entry. The DEPDC1B
protein specifically accumulates at the G2 phase of the cell cycle
and inhibits RhoA recruitment to and activation by the FA-asso-
ciated receptor protein tyrosine phosphatase, receptor type,
F (PTPRF). By this mechanism, DEPDC1B functions as an inhib-
itor of the RhoA/Rho-associate protein kinase (ROCK)/MLC2Authors
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Figure 1. DEPDC1B Silencing Delays
Mitotic Entry in Human Cells
(A and B) HeLa cells were synchronized in S phase
by D-THY and released in fresh medium with no-
codazole (100 nM) to follow cell-cycle progression
from S phase to mitosis. During synchroniza-
tion, endogenous DEPDC1B was silenced using
different siRNA oligos (1B-KD1, 1B-KD2, or 1B-
KD3). A custom non-targeting oligo was used as a
control. Mitotic cells were monitored using mitotic-
specific phosphorylation of histone H3 (Ser-10) as
a marker (mean ± SEM of three experiments).
(B) Cells were transduced with an inducible EGFP-
DEPDC1B transgene (EGFP-1B) and synchronized
as in (A). Endogenous DEPDC1B was silenced
using a 30UTR-targeting oligo (1B-KD3). Upon
release, siRNA-resistant EGFP-1B was induced
by doxycycline (100 ng/ml), and mitotic cells were
counted. Western blot shows levels of endoge-
nous and exogenous DEPDC1B. Vinculin was
used as loading control.
(C) Mitotic events were directly measured by time-
lapsemicroscopy. The percentage of cells entering
mitosis upon silencing of DEPDC1B, DEPDC1A, or
both genes (KD-1A/KD-1B) is shown.
(D) Cell-cycle transitions were monitored by flow
cytometry. DNA content (propidium iodide stain-
ing) of control (Ctrl) and DEPDC1B-silenced cells
(1B-KD1) are shown. The percentage (mean ±
SEM of two experiments) of cells in G2 phase
(cyclin B positive) and M phase (pH3/cyclin B
double positive) were determined.
(E and F) Lamin B/cyclin B staining and distribution
(mean ± SEM of three experiments) were analyzed
to monitor mitotic entry dynamics. The distribution
of lamin B (membrane versus diffuse [E]) and cyclin
B (nucleus versus cytosol, see F) of cells in G2
phase is shown. Asterisks mark nuclear cyclin B or
membrane laminB.Arrowsmarkcytosolic cyclinB.
(G) Western blot analysis of cyclin B and total/
phospho-Cdk1 (Tyr14/15). Vinculin was used as
loading control. The densitometry analysis is also
reported (mean ± SEM of two experiments). As-
terisks in graphs mark significant values (p < 0.05,
Student’s t test). Representative images are
shown. Scale bars represent 20 mm.
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DEPDC1B/RhoA/PTPRF Axis Controls G2/M Transitionpathway during the G2/M transition, thereby allowing FA
dismantling and cell detachment. Ablation of DEPDC1B
impaired de-adhesion events and delayed mitotic entry. Simi-
larly, conditions that induced persistent adhesion to the sub-
strate, independently of DEPDC1B, inhibited mitotic entry,
suggesting that adhesion per se controls cell-cycle progression.
Thus, we have identified a feedback loop in which the nucleus
signals to cell periphery the need to initiate mitotic reshaping
through the synthesis of DEPDC1B. In turn, adhesion-dependent
mechanisms delay progression into the M phase until mitotic
reshaping is correctly executed.
RESULTS
DEPDC1B Regulates Mitotic Entry
DEPDC1B is a proliferation-associated gene expressed in a cell-
cycle-dependent fashion through an Rb/E2F-dependent tran-
scriptional mechanism (Nicassio et al., 2005). We examinedDevelopmethe pattern of expression of DEPDC1B mRNA and protein in
HeLa cells synchronized by double-thymidine block (D-THY;
Figure S1A available online). As cells entered the G2 phase
(4 hr after release), DEPDC1B mRNA was induced, and the pro-
tein accumulated until mitosis (M phase, 8 hr), closely resembling
the behavior of cyclin B. In addition, similar to cyclin B,
DEPDC1B protein was degraded during mitosis in a protea-
some-dependent manner (Hershko, 1999) (Figure S1B).
Knockdown (KD) of DEPDC1B with three different short inter-
fering RNA (siRNA) oligos (1B-KD1, 1B-KD2, 1B-KD3; Figures
1A, 1B, and S1C) in HeLa cells synchronized by D-THY reduced
the number of cells that reached mitosis (Figures 1A–1C; Movie
S1), an effect that could be rescued by the concomitant expres-
sion of a siRNA resistant GFP-tagged DEPDC1B (Figures 1B
and 1C). Flow-cytometry analysis showed that DEPDC1B-KD
cells progressed normally from S to G2 (G2 phase, Figure 1D),
while the transition from G2 to mitosis (mitosis, Figure 1D) was
inhibited. Silencing of DEPDC1B also inhibited mitotic entry inntal Cell 31, 420–433, November 24, 2014 ª2014 The Authors 421
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Figure 2. DEPDC1B Silencing Perturbs Adhesion and Actin Cytoskeleton Dynamics in G2 Phase
(A andB) FA dynamicswere observed usingGFP-paxillin (A) or vinculin (B) as reporters in control (Ctrl) or DEPDC1B-silenced (1B-KD1) HeLa cells synchronized in
early G2 phase (D-THY plus 4 hr release). (A) The mean number, size (area, mm2), and the duration of FAs, determined by total internal reflection fluorescence
(TIRF) microscopy, in control (Ctrl, blue) and DEPDC1B-silenced cells (KD-1B, red) are shown. (B) The average number and area (mm2) of FAs per cell, determined
by confocal microscopy using vinculin staining, are shown.
(C) The actin cytoskeleton (FITC-phalloidin) and the activation of myosin light chain (phospho-MLC2-Ser19) were analyzed by immunofluorescence and confocal
microscopy in HeLa cells synchronized in G2 phase. The percentage (mean ± SEM of three experiments) of cells with high/low phospho-MLC2 staining is
reported.
(legend continued on next page)
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DEPDC1B/RhoA/PTPRF Axis Controls G2/M Transitionother cell types, including nontransformed and cancer cell lines
(Figure S1D).
A DEPDC1B-like gene,DEPDC1A, encodes two isoforms (Fig-
ure S1E) whose expression is also regulated during the cell cycle
(Figure S1F). Silencing of DEPDC1A caused a mitotic phenotype
similar to that of DEPDC1B-KD (Figures 1C, S1G, and S1H).
Importantly, the simultaneous depletion of both genes had addi-
tive and robust effects (Figures 1C, S1G, and S1H), arguing for
functional redundancy and tight cooperative control over the
G2/M transition.
We investigated the effects of DEPDC1B silencing on the key
molecular events of the G2/M transition (Gu¨ttinger et al., 2009;
Lindqvist et al., 2009). Upon DEPDC1B silencing, the nuclear
membrane abnormally persisted in the majority of cells (lamin
B staining, Figure 1E), while no differences were found in cyclin
B expression (Figures 1F–1G). However, nuclear accumulation
of cyclin B was decreased (Figure 1F), suggesting that activation
of the MPF could be impaired. Thus, we investigated the phos-
phorylation status of CDK1 since dephosphorylation on Tyr14/
15 is required for progression into mitosis (Hunter, 1995). The
phosphorylation of CDK1 in DEPDC1B-KD cells was increased
and sustained in time compared with control cells, confirming
that MPF activation was delayed (Figure 1G). Together these re-
sults indicate that DEPDC1B is a regulator of theG2/M transition,
acting upstream of the MPF activation.
DEPDC1B Modulates Adhesion and Actin Cytoskeleton
Dynamics in G2
We employed the GFP-tagged version of DEPDC1B to analyze
its subcellular distribution. In G2-syncronized cells, we observed
a plasma membrane (PM) localization of DEPDC1B that per-
sisted during mitosis (Figures S2A and S2B). In addition, while
control cells lost attachment to the substrate and became
rounded as they approached mitosis, DEPDC1B-KD cells ap-
peared flattened, more motile, and often failed to detach from
the substrate and become rounded (Movie S1). DEPDC1B
might, therefore, act at the PM to regulate cellular adhesion.
We investigated this possibility by following the dynamics of
GFP-paxillin, a marker of FAs (Parsons et al., 2010; Zamir and
Geiger, 2001). In control cells, the typical punctuate staining of
GFP-paxillin at the ventral membrane, which marks FAs in inter-
phase, quickly disappeared as cells approached mitosis (Fig-
ure 2A; Movie S2). Conversely, DEPDC1B-KD cells displayed
larger FAs that persisted in G2 (Figure 2A; Movie S2). A quantita-
tive analysis revealed that the absolute number of FAs per cell
was unaffected; however, their size was significantly increased
and their mitotic dismantling delayed (Figures 2A, 2B, S2C,
and S2D).
We also detected significant modifications of actin dynamics
in DEPDC1B-KD HeLa cells in G2 phase, with cells displaying(D) Western blot analysis shows levels of phospho-MLC2, phospho-Cofilin (Ser3
controls. In parallel, RhoA activity was measured by GST-RBD pull-down (right p
asterisk marks a nonspecific band detected by the anti-RhoA antibody. The den
(E) IMR90 andMCF10A cells were analyzed in G2 phase for actin cytoskeleton and
phospho-MLC2 (Ser19) upon DEPDC1B silencing.
(F) Cell spreading dynamics, on fibronectin substrate, of G2 synchronized HeLa
shows the normalized cell index, as a measure of cell-covered area after replating
Student’s t test in C). Representative images are shown. Scale bars represent 1
Developmean altered pattern of actin stress fibers and increased phosphor-
ylation of the actin regulator myosin light chain 2 (MLC2-Ser19), a
typical downstream target of the ROCK, and cofilin (pCofilin-
Ser3) (Figures 2C and 2D). These observations could be
extended to other cell types, including fibroblasts and nontrans-
formed epithelial cells (Figure 2E). Finally, the silencing of
DEPDC1B also altered the dynamics of cells spreading, an effect
that could be rescued by the ectopic expression of the siRNA-
resistant GFP-DEPDC1B (Figures 2F and S2E).
These results point to a role for DEPDC1B in the control of
cellular adhesion and actin dynamics during the G2 phase of
the cell cycle.
DEPDC1B-KD Induces an Adhesion-Dependent
Checkpoint at the G2/M Transition
We investigated the relationship between the mitotic and the
adhesion phenotypes caused by DEPDC1B silencing. Initially,
we took advantage of a HeLa derivative clone (HeLa-S3)
adapted to growth in suspension (Puck et al., 1956) (Figure 3A).
In these cells, DEPDC1B-KD did not affect the G2/M transition
(Figure 3B), arguing that in the absence of cell adhesion the
mitotic phenotype of DEPDC1B-KD cells could be suppressed.
If so, it should be possible to abrogate the said phenotype
by directly interfering with FAs. Thus, we silenced structural
(vinculin, alpha-actinin) and catalytic (FAK) components of
FAs in DEPDC1B-silenced cells (Figure 3C). In all cases, the
downmodulation of FA components completely rescued the
DEPDC1B-KD-dependent mitotic delay (Figure 3D), indicating
that, in DEPDC1B-KD cells, the cell-cycle phenotype is linked
to the abnormal persistence of FAs at the G2/M transition
phase.
We also analyzed the involvement of actomyosin contractility,
which was altered upon DEPDC1B silencing (see Figure 2). As
mentioned above, this process is closely linked to cell adhesion
mechanisms and is controlled by RhoA/ROCK/MLC2 signaling.
Therefore, we treated G2 synchronized DEPDC1B-KD cells
with a ROCK inhibitor (Y27632, 10 mM). The treatment normal-
ized the levels of phospho-MLC2 and concomitantly rescued
themitotic phenotype in DEPDC1B-KD cells (Figures 3E and 3F).
If the impairment in G2/M transition observed in DEPDC1B-KD
cells were indeed due to the persistence of FAs, then induction of
persistent adhesive structures should phenocopy the DEPDC1B
silencing. To investigate this, we employed two tools: (1) an auto-
inhibition-deficient mutant of vinculin (VincT12mutant), which in-
creases adhesion strength and force transmission (Humphries
et al., 2007), and (2) manganese treatment (Mn2+, 1 mM), which
induces anb3 integrin activation and clustering (Cluzel et al.,
2005; Gailit and Ruoslahti, 1988). In G2-synchronized HeLa cells,
both treatments induced cell spreading on the substrate, forma-
tion of actin stress fibers, and high levels of phospho-MLC2) upon DEPDC1B-KD. Vinculin, total MLC2, and Cofilin were used as loading
anel). As positive control, the lysate was activated by GTPgS stimulation. An
sitometry analysis of active RhoA in two experiments is shown.
FA dynamics as described in (B) and (C). Western blot analysis shows levels of
cells was monitored by Real Time Cell Analyzer (Atienzar et al., 2011). Graph
. Asterisks in graphs mark significant values (p < 0.05, Wilcoxon test in A and B;
0 mm.
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Figure 3. DEPDC1B Controls an Adhe-
sion-Dependent Checkpoint at the G2/M
Transition
(A and B) HeLa (grown in adhesion) and HeLa-S3
(grown in suspension) cells were treated with
control or DEPDC1B siRNAs and synchronized
(D-THY) to follow cell-cycle progression. (B) Per-
centage of cyclin B-positive (G2 phase) and pH3/
cyclin B double-positive (mitosis) cells were
determined by flow cytometry.
(C and D) Control (Ctrl) or DEPDC1B-silenced (1B-
KD1) HeLa cells were treated either with vinculin,
FAK, or alpha-actinin siRNA oligos. (D) Mitotic
events were measured using pH3 marker (mean ±
SEM of three experiments).
(E and F) Control (Ctrl) or DEPDC1B-silenced (1B-
KD1) HeLa cells were synchronized as in (A) and
treated with the ROCK kinase inhibitor (Y27632,
10 mM) upon release. Mitotic cells were measured
using pH3 staining (E) or by time-lapsemicroscopy
(F). Western blot analysis shows levels of phos-
pho-MLC2 on DEPDC1B-KD and Y27632 treat-
ment. Vinculin and total MLC2 were used as
loading controls.
(G) HeLa cells were synchronized (as in A) and
treated upon release with Mn2+ (1 mM, upper
panel). In the lower panel, HeLa cells were trans-
fected with pEGFP-vinculin (VincT12 mutant) dur-
ing synchronization. Western blot analysis shows
levels of phospho-MLC2 and phospho-CDK1
upon Mn2+ treatment and VincT12 expression.
RhoA activation by Mn2+ treatment was measured
by RBD pull-down. An asterisk marks a nonspe-
cific band detected by the anti-RhoA antibody.
(H and I) Mitotic cells were measured using pH3
staining (H and I) or cyclin B distribution (H). Scale
bar graphs report the mean ± SEM of three (C
and D) or two (B, E, H, and I) experiments. Aster-
isks mark significant values (p < 0.05, Student’s
t test).
Developmental Cell
DEPDC1B/RhoA/PTPRF Axis Controls G2/M Transition(Figures 3G and S3A–S3D), while concomitantly inhibiting the
G2/M transition (Figures 3H–3I and S3E).
These results suggest the existence of a DEPDC1B-based
mechanism that controls the coordination of adhesion and actin
cytoskeleton dynamics with entry into mitosis. Of note, the G2/M
arrest induced by DNA damage-inducing agents (i.e., doxoru-
bicin) appeared stronger than the cell-cycle arrest induced by
persistent adhesion (Figures S3E and 3F).
DEPDC1BModulates RhoA-Dependent Cell Adhesion at
G2/M Transition
Since both actin cytoskeleton and adhesion dynamics are regu-
lated by Rho-GTPases, we silenced the expression of each of
the three prototypical members of this family, RhoA, Rac1, and
Cdc42, alone and in conjunction with DEPDC1B-KD. The deple-
tion of any of the three Rho-GTPases alone had no major effect
on G2/M transition (Figure 4A). However, RhoA silencing, but
not Rac1 or Cdc42 silencing, completely rescued the mitotic
delay induced by DEPDC1B silencing (Figures 4A and 4B).
Furthermore, the significant increase in the size of FAs in
DEPDC1B-KD cells (see Figures 2A and 2B) was fully rescued424 Developmental Cell 31, 420–433, November 24, 2014 ª2014 Theby silencing RhoA (Figures 4C–4E). Finally, the DEPDC1B-KD-
dependent spreading defect was rescued by silencing of
RhoA, but not of Rac1 or Cdc42 (Figure S4A). These results
link the function of DEPDC1B to the control of RhoA activity,
likely through inhibition of the latter at the G2/M transition. This
notion is further supported by the observations that (1) the
DEPDC1B silencing increased the activity of RhoA (RBD pull-
down assay, Figure 2D), (2) the levels of downstream targets,
such as phospho-MLC2 (Figures 2C–2E), (3) RhoA overexpres-
sion in G2 cells phenocopied DEPDC1B KD, causing an increase
in the size of FAs and in the levels of phospho-MLC2 (Figures 4F–
4G) and a decrease in the mitotic index (Figure 4H).
PTPRF Controls RhoA-Dependent Signaling at Mitotic
Entry
Despite having a RhoGAP-like (GTPase-activating) domain (Fig-
ure S1E), DEPDC1B ismost likely not an active GAP since it lacks
the catalytic arginine typical of true RhoGAPs (Graham et al.,
1999; Rittinger et al., 1997) (Figure S4B). Indeed, we failed to
detect RhoGAP activity of the recombinant RhoGAP domain of
DEPDC1B (Figure S4C).Authors
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Figure 4. DEPDC1B Controls RhoA-Dependent Cell Adhesion at the G2/M Transition
(A and B) Control (Ctrl) or DEPDC1B-silenced (1B-KD1) D-THY synchronized HeLa cells were treated with RhoA, Rac1, or Cdc42 siRNA oligos. Mitotic cells were
measured using pH3 staining (A) or by time-lapse microscopy (B).
(C–E) HeLa cells were treated with control, DEPDC1B and RhoA siRNA oligos as indicated and synchronized in G2 phase. Staining for pH3 was used to
distinguish G2 from mitotic cells. G2 cells were examined for FAs (using vinculin as marker) and actin cytoskeleton (Phalloidin). (D and E) The distribution of FA
mean area per cell (D) or percentage of cells displaying enlarged FAs and actin stress fibers (E) are shown.
(F–H) HeLa cells were transfected with RhoA-myc and synchronized in G2 (F and G) or M phase (H). (F) Western blot analysis shows levels of RhoA-myc and
phospho-MLC2. Total MLC2 was used as loading control. In parallel, FA dynamics were analyzed by vinculin staining. (G and H) Bar graphs show the percentage
of cells with normal/enlarged FAs and actin stress fibers (G) and the percentage of pH3-positive cells (H). Scale bar graphs report the mean ± SEM of three (A, D,
and E) or two (F and H) experiments. Asterisks mark significant values (p < 0.05, Student’s t test). Representative images are shown. Scale bars represent 10 mm.
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DEPDC1B/RhoA/PTPRF Axis Controls G2/M TransitionTo understand how DEPDC1B modulates RhoA signaling,
we performed a yeast-two-hybrid (Y2H) screening to identify
DEPDC1B-interacting proteins. Most of the hits were repre-
sented by PTPRF (Figure 5A; Table S1), a transmembrane recep-
tor that has been suggested to function as a molecular hub atDevelopmeadhesive sites that coordinates adhesion and migration events
(Chagnon et al., 2004; Serra-Page`s et al., 1995; Tsujikawa
et al., 2002). We confirmed the direct biochemical interaction
between the DEPDC1B and PTPRF by glutathione S trans-
ferase (GST) pull-down experiments performed with cell lysatesntal Cell 31, 420–433, November 24, 2014 ª2014 The Authors 425
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Figure 5. The Membrane Receptor PTPRF Interacts Biochemically and Genetically with DEPDC1B and RhoA
(A) An Y2H screen was employed to search for DEPDC1B interactors. The chart shows the distribution of positive clones.
(B and C) GST-PTPRF-c (cytoplasmic fragment, 1 mM) was incubated with total lysates (2 mg) from HeLa cells overexpressing EGFP-1B (B) or from control HeLa
cells (C). Western blot analysis was performed using anti-GFP or anti-DEPDC1B antibodies. Asterisk marks a non-specific band detected by the anti-GFP.
Ponceau staining is shown.
(D) GST-PTPRF-c (1 mM) was incubated with the purified GAP domain of DEPDC1B (1B-GAP, 3 mM). Proteins were resolved by SDS-PAGE and detected by
Coomassie staining to reveal the amount of 1B-GAP pulled down by PTPRF-c.
(E and F) Control (Ctrl) or DEPDC1B-silenced (1B-KD1) HeLa cells were synchronized and treated or not with PTPRF siRNA. (E) Mitotic cells were measured using
pH3-staining (mean ± SEMof three experiments). Asterisksmark significant values (p < 0.05, Student’s t test). (F)Western blot analysis shows levels of DEPDC1B,
PTPRF, and phospho-MLC2. Vinculin and total MLC2 were used as loading controls.
(legend continued on next page)
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tion was also confirmed in intact cells by coimmunoprecipitation
of GFP-tagged DEPDC1B and overexpressed PTPRF (Fig-
ure S5A) and by colocalization of the two proteins at the PM
(Figure S5B).
Next, we investigated whether PTPRF is involved in the
DEPDC1B-dependent phenotypes. PTPRF-KD impaired cell
spreading onto fibronectin, as previously shown (Figure S5C;
Asperti et al., 2009), while it did not cause appreciable effects
on the rate of mitotic entry (Figures 5E and 5F). However, PTPRF
silencing was able to rescue both the mitotic delay and the
increase in phospho-MLC2 levels induced by DEPDC1B
silencing (Figures 5E and 5F), suggesting its participation in the
DEPDC1B-dependent mechanisms that control actin dynamics
at the G2/M transition. PTPRF phosphatase activity appeared
not to be involved since PTPRF interaction with DEPDC1B was
not affected by phosphatase treatment and treatment with inhib-
itors of PTPRF phosphatase activity did not significantly affect
mitotic entry alone or together with DEPDC1B silencing (Figures
S6A and S6B).
To gain further insights into the role of PTPRF, we examined
the PTPRF interactome by mass spectrometry. The list of
PTPRF-interacting proteins was significantly enriched in compo-
nents of the RhoA/ROCK pathway (p < 0.001; Figures 5G and
S5D), including RhoA itself and several RhoA-binding partners,
such as its effectors ROCK2 and mDIA1, as well as members
of the actin network (Table S2). The direct interaction between
PTPRF and RhoA was confirmed in in vitro pull-down experi-
ments, largely independently of the activation status of the latter
(Figures 5H and S5E) and by colocalization at the PM (Fig-
ure S6C). Importantly, the silencing of PTPRF reversed the
mitotic defect induced by RhoA overexpression, albeit not
completely (Figures 5I and 5J). Among PTPRF-interacting pro-
teins, we identified several guanine nucleotide exchange factors
(GEFs), and most notably GEF-H1, suggesting that the PTPRF/
GEF-H1 axis could be involved in RhoA activation at FAs.
This contention is reinforced by the observations that (1)
PTPRF localizes at the PM close to FAmarkers (vinculin, paxillin)
and to RhoA (Figures S6C–S6E); (2) the interaction between
GEF-H1 and PTPRF was confirmed in a pull-down assay (Fig-
ure 6A); (3) silencing of GEF-H1, but not of another GEF, PDZ-
GEF, which was pulled down by PTPRF, rescued the mitotic
phenotype induced by DEPDC1B silencing (Figure 6B); (4) over-
expression of GEF-H1 phenocopied the effect of RhoA activation
or DEPDC1B silencing, inhibitingmitotic entry and inducing actin
stress fibers (Figure 6C).
RhoA:PTPRF Interaction Depends on DEPDC1B Levels
The sum of our results strongly supports a model in which RhoA/
ROCK signaling in G2 phase is induced by PTPRF/GEF-H1 and
is inhibited by DEPDC1B. One mechanism through which this
might occur is competition of the interaction of RhoAwith PTPRF(G) Mass spectrometry analysis of proteins pulled down using GST or GST-PTPRF
PTPRF interactors.
(H) Coomassie Staining of GST-PTPRF-c pull-down assay (1 mM), using purified
(I and J) HeLa cells were transfected with RhoA-myc, treated with control or PTP
(I) Western blot analysis shows levels of RhoA-myc, PTPRF, and vinculin (loadin
(mean ± SEM of two experiments) using pH3 staining as a mitotic marker. Asteri
Developmeby DEPDC1B, with ensuing inhibition of the RhoA signaling com-
plex and the consequent dismantling of adhesion structures at
the G2/M transition. We tested this hypothesis through a series
of experiments. We showed by in vitro pull-down assays per-
formed on total cellular lysates that the interaction between the
cytoplasmic domain of PTPRF (GST-PTPRF-c) and RhoA was
almost completely inhibited by the simultaneous presence of
excess DEPDC1B (obtained by ectopic expression) in the cell
lysate (Figure 6D). This effect on PTPRF and RhoA binding was
also reproduced in stable isotope labeling by amino acids in
cell culture (SILAC) experiments (Figure 6E) and appears specific
for RhoA itself since binding of GEF-H1 (RhoA activator),
ROCK2, and mDIA1 (RhoA effectors) to PTPRF were unaffected
by DEPDC1B overexpression (Figures 6A and 6F). Conversely,
silencing DEPDC1B significantly increased the interaction be-
tween GST-PTPRF-c and RhoA in the same assay (Figure 6G)
and the interaction between RhoA and ROCK2 in the RBD pull-
down assay (Figure 6H). Finally, the purified DEPDC1B fragment
that interacts with PTPRF-c (Figure 5D) halved the interaction of
the latter with RhoA in in vitro pull-down experiments (Figure 6I).
These results suggest a role for the DEPDC1B-PTPRF axis in
the control of RhoA signaling at mitotic entry, with DEPDC1B
acting as negative regulator of the recruitment of RhoA to
PTPRF-based complexes (Figure 6J).
DEPDC1BModulates Cell Proliferation during Zebrafish
Embryogenesis
To analyze the relevance of the DEPDC1B/RhoA/PTPRF axis at
the organismal level, we turned to zebrafish, which express a
DEPDC1B ortholog (depdc1b) that has an exon/intron organiza-
tion conserved with the human gene (Figure S7A) and 75%
similarity to the human protein. By in situ hybridization and RT-
qPCR of zebrafish embryos, we showed that depdc1b mRNA
has no maternal contribution, first appeared at 3 hr postfertiliza-
tion (hpf), and gradually accumulated until the end of segmenta-
tion period (32 hpf), with more intense expression detected in the
head and dorsal regions (Figures 7A and S7B).
The function of Depdc1b during zebrafish development was
investigated by taking advantage of a specific splice-blocking
morpholino (MOSB) to induce the formation of a truncated pro-
tein (Figure S7C). The injection of a depdc1b-MOSB caused a
severe morphological defect, already visible at the late gastrula
stage (10 hpf; Figure 7B), possibly due to alterations in morpho-
genetic mechanisms, and finally displaying a phenotype at 24
hpf characteristic of mutations with delayed or incomplete epib-
oly (Kane et al., 1996; Figure 7B). We investigated the effects of
Depdc1b ablation on cell proliferation by measuring the mitotic
rate in the anterodorsal side of the embryo, where Depdc1B is
preponderantly expressed. We used the Tg(h2afva:GFP)kca6
transgenic line (Pauls et al., 2001), in which the fusion protein his-
tone variant H2A.F/Z:GFP is expressed from the start of zygotic
transcription, to monitor mitosis. Real-time analysis in the dorsal-c identified several members of RhoA signaling pathway (listed in the table) as
RhoA (3 mM).
RF-targeting siRNA oligo, and synchronized in S phase to follow mitotic entry.
g control). (J) Scale bar graphs report the percentage of cells entering mitosis
sks mark significant values (p < 0.05, Student’s t test).
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Figure 6. PTPRF as a Hub for the Activation of the RhoA Signaling Complex, which Is Dependent on DEPDC1B Protein Levels
(A) GST-PTPRF-c pull-down assay with total lysates (1 mg) from HeLa control cells or cells overexpressing 1B-GFP. Western blot analysis shows levels of GEF-
H1 and 1B-GFP.
(B and C) The effects of silencing or overexpression of GEF-H1 has been analyzed on HeLa cells. Bar graphs report the percentage of cells entering mitosis
(mean ± SEM of two experiments) using pH3 staining as mitotic marker. Asterisks mark significant values (p < 0.05, Student’s t test). (B) A bar graph on the right
shows the relative mRNA expression of another RhoA GEF, PDZ-GEF, upon silencing. (C, below) Western blot shows levels of GEF-H1 upon silencing or
overexpression and vinculin (loading control). (Above) Representative images of FAs (vinculin) and actin cytoskeleton (phalloidin) of control HeLa cells or cells
overexpressing GEF-H1. Scale bars represent 10 mm.
(D–G) GST-PTPRF-c pull-down assays were performed with total lysates (1 mg) from control cells, cells overexpressing both 1B-GFP and RhoA-GFP (D), cells
overexpressing just 1B-GFP (E and F), cells overexpressing RhoA-myc and silenced for endogenous DEPDC1B (G). Western blot analysis was performed using
the anti-GFP antibody for both 1B-GFP and RhoA-GFP, the anti-myc antibody for RhoA-myc, the anti-mDIA1 or anti-ROCK2 antibodies (RhoA downstream
effectors), or anti-DEPDC1B antibody. The asteriskmarks a nonspecific band detected by the anti-GFP antibody (D and F). In (E), protein bound to PTPRF-c were
(legend continued on next page)
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7D) scored a defect upon depdc1b-MOSB injection in mitotic
events occurring between 5 and 6 hpf. We did not detect alter-
ations in mitotic duration per se (Figure 7E), suggesting that
the defect in mitotic peaks was caused by a premitotic defect,
possibly in the control of the G2/M transition as observed in
mammalian cells. At 10 hpf the developmental defects of
depdc1b-morphant embryos were mirrored by an increase in
proliferation (number of pH3+ cells) of anterodorsal region (Fig-
ure 7F). At this stage, we also observed a series of cytoskeleton
related phenotypes, such as cells with much irregular shape,
thickening of cortical actin, and frequent appearance of actin
protrusions on cell edges (Figures 7G and 7H). All of these de-
fects were rescued by the coexpression of human DEPDC1B
mRNA, suggesting that the phenotype was specifically caused
by Depdc1b ablation and that Depdc1b function is conserved
(Figures 7F–7H and S7D). To corroborate this possibility, we
tested whether the DEPDC1B genetic interactions identified in
mammals were conserved in zebrafish, by analyzing the effect
of ablation of the RhoA and PTPRF zebrafish orthologs (rhoab
and ptprf, respectively). KD of either rhoab or ptprf by MOSB in-
jection (Figure S7C) rescued all of the defects of the depdc1b
morphants observed at 6, 10, and 24 hpf (Figures 7I, 7F,
and S7D), suggesting that the DEPDC1B/RhoA/PTPRF axis
is conserved. Of note, neither the isolated DEP domain nor
the pseudo-RhoGAP domain of DEPDC1B was sufficient to
rescue the MOSB phenotype, suggesting that both domains
are required for complementing DEPDC1B functions in vivo
(Figure S7E).
DISCUSSION
We have uncovered a feedback mechanism of communication
between the nucleus and the cell periphery that is centered on
DEPDC1B and that allows the coordination and control of a se-
ries of events critical to the correct execution of the mitotic pro-
gram. Mechanistically, this occurs through the RhoA-dependent
regulation of FA clustering and actin dynamics and the PTPRF-
dependent regulation of the RhoA signaling complex in proximity
to FAs. The impact of the DEPDC1B/RhoA/PTPRF circuitry is not
limited to 2D cell culture settings but extends to real 3D situa-
tions, as observed in zebrafish development.
Signaling from the Nucleus to the Cell Periphery
The levels of DEPDC1B oscillate during the cell cycle with
behavior and mechanisms indistinguishable from those of
checkpoint proteins, such as cyclin B. This cyclin-like regulation
is critical for mammalian cell proliferation. Indeed, a lack ofidentified and quantified by SILAC in presence or not of DEPDC1B-GFP overex
of isotope-encoded amino acid among the two channels). Among PTPRF int
downmodulated by DEPDC1B overexpression (>1 log2 fold), such as DEPDC1B
(H)Western blot analysis shows levels of ROCK2 (RhoA effector) bound to active R
control, the lysate was activated by GTPgS stimulation.
(I) GST-PTPRF-c (1 mM) was incubated with purified RhoA (3 mM) and/or 1B-GA
staining to reveal the amount of protein pulled down by PTPRF-c. The densitomet
is shown.
(J) The scheme depicts the working model for DEPDC1B as a competitive inhib
signaling that regulates the adhesion dynamics of G2 cells andmitotic entry. Posit
reported, according to the findings of this study.
DevelopmeDEPDC1B produces two clear phenotypes: (1) a cell-cycle ef-
fect, consisting in a significant delay in the transition to mitosis
(an effect greatly augmented by the concomitant depletion of
DEPDC1A), and (2) an adhesion/cytoskeleton phenotype, with
cells displaying enlarged and persistent FAs and aberrant actin
stress fibers formation. The two phenotypes are intimately con-
nected, since under conditions that promote de-adhesion (or
upon growth in suspension) the mitotic defect is completely by-
passed. Accordingly, impairment of the de-adhesion process,
produced by outside-in (integrin clustering and increased force
transmission) or inside-out (RhoA ectopic expression) mecha-
nisms, resulted in a defect in cell-cycle progression that was
comparable in all experimental conditions (Figure S3E and sum-
marized in Figure 6J). We conclude that we have identified an
‘‘adhesion-dependent checkpoint’’ that participates in the regu-
lation of the G2/M transition and affects most, but not all the
cells (a few still reach mitosis). Thus, the ‘‘adhesion-dependent
checkpoint’’ appears a little less strong than a typical G2 check-
point, such as the one induced uponDNAdamage, which usually
affects all the cells.
Signaling at the Cell Periphery
At the PM, two major processes contribute to cell shape remod-
eling of cells that entermitosis: FA dismantling (de-adhesion) and
cortical stiffening (mitotic rounding). The process of de-adhesion
was previously shown to be under the control of the Rap1-
GTPase, whose cell-cycle-specific downmodulation, by an as-
yet-unknown mechanism, is critical to inhibit the formation of
new FA sites and to shut down integrin signaling (Dao et al.,
2009). Conversely, mitotic rounding does not apparently involve
attenuation of Rap1 signaling, as it was shown that cells ex-
pressing a Rap1 dominant-negative mutant (Rap1*) could enter
mitosis and displayed some kind of rounding and contractility
while remaining attached to the substrate (Dao et al., 2009; Lan-
caster et al., 2013). Cell rounding, instead, is thought to be due to
RhoA- and ERM-dependent control of cortical rigidity (Kunda
and Baum, 2009; Kunda et al., 2008; Maddox and Burridge,
2003; Matthews et al., 2012). Therefore, it is likely that two path-
ways, one regulating FA dismantling (Rap1 dependent) and the
other regulating mitotic rounding (RhoA and ERM dependent),
exist and cooperate to induce cell reshaping at mitosis. Our
data argue that both these pathways are under the control of
DEPDC1B.
The control on FA dynamics exerted by DEPDC1B is due to its
ability to bind to PTPRF and to compete specifically with RhoA
for binding to this hub, thereby inhibiting activation of the RhoA
signaling (likely due to GEF-H1) and actomyosin contractility
at adhesion sites. It remains to be established how thepression (two independent experiments, forward and reverse, with swapping
eractors, 39 proteins were found with binding consistently upmodulated or
itself and RhoA.
hoA (RBD-pull-down) upon DEPDC1B silencing or Mn2+ treatment. As positive
P (3 mM). Proteins were resolved by SDS-PAGE and detected by Coomassie
ry analysis of the PTPRF-c/RhoA (and 1B-GAP) interaction in three experiments
itor of the RhoA/PTPRF interaction resulting in inhibition of RhoA-dependent
ive (left) and negative (right) inducers of the G2/M adhesion checkpoint are also
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Figure 7. DEPDC1B Controls Mitotic Events in Zebrafish Embryo
(A) Zebrafish (ZF) embryos were collected at different times from fertilization (hpf) and levels of depdc1b or depdc1amRNA expression measured by RT-qPCR.
Actin B (Actb) was used as a normalizer.
(B) ZF embryos were injected with control or depdc1b splice-blocking morpholino (MOSB) at the one-cell stage. Pictures show representative images of the
resultingmorphological defects observed at the late gastrula (10 hpf, left) or late segmentation (24 hpf, right) stages. Scale bars represent 125 mm (left) and 500 mm
(right).
(C–I) Zebrafish embryos were treated as in (B), andmitotic figures were monitored in the embryonic dorsal region of the Tg(h2afva:GFP)kca6 zebrafish transgenic
line using confocal microscopy. Representative images are shown in (C).The scale bar represents 10 mm.
(D) The graphs show the number of mitotic events (mean ± SD of two experiments) occurring from 4 to 6 hpf. DEPDC1B humanmRNAwasmicroinjected together
with depdc1b MOSB to rescue embryo defects.
(E) Duration of mitotic phases (mean ± SEM) was measured by confocal time-lapse microscopy, after MBT.
(legend continued on next page)
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Rap1-dependent de-adhesion. The role of DEPDC1B in cortical
actin dynamics, on the other hand, presents us with an apparent
paradox, since DEPDC1B is a functional inhibitor of RhoA
signaling at PTPRF-based hubs, while the increase in cortical
rigidity needed for mitotic rounding requires active RhoA. This
latter event occurs just before prophase, through the Rho-GEF
ECT2 (Matthews et al., 2012). Based on our results, a simple
reconciling scenario might be that RhoA, once displaced by
DEPDC1B from PTPRF sites during late G2, becomes available
for ECT2-dependent activation at other sites of the PM later in
the cell cycle when cells are in prophase. The precise order of
events should be guaranteed by the fact that lack of DEPDC1B
accumulation impacts onMPF activation, which, in turn, controls
ECT2 translocation from the nucleus to the PM (Matthews et al.,
2012).
Signaling from the Cell Periphery to the Nucleus
Our data show that DEPDC1B not only coordinates FA disas-
sembly withmitotic rounding at the PMbut also signals to the nu-
cleus to time entry of cells intomitosis, acting at a point upstream
of the MPF complex. This signaling appears dependent on the
decrease of RhoA activity at FAs, as suggested by the compre-
hensive analysis of our molecular genetics and biochemical
evidence. The exact nature of the molecular network linking
adhesion signaling to nuclear MPF activation at the G2/M transi-
tion remains to be elucidated. Possible candidates includemem-
bers of MAPK-ERK cascade, which are known to have a role
in cyclin B activation during mitotic entry (Patel et al., 1999;
Wang et al., 2007), as well as to be activated upon FA establish-
ment and stabilization (reviewed in Margadant et al., 2013).
In summary, we uncovered a mechanism coordinating cell
adhesion with cell-cycle progression that acts as a cell-cycle
‘‘adhesion-dependent checkpoint’’ and demonstrated the
relevance of this mechanism in vivo. Of note, the molecular com-
ponents of this checkpoint, including DEPDC1B, PTPRF and
RhoA, are frequently altered in cancer. Thus, the subversion
of the adhesion-dependent checkpoint might also be rele-
vant to human pathology: a possibility that warrants further
investigations.
EXPERIMENTAL PROCEDURES
Cell-Cycle Synchronization and Procedures
HeLa, Phoenix, and U2OS cells were cultured in Dulbecco’s modified Eagle’s
mediumplus fetal bovine serum (10%v/v), L-glutamine (2mM), and sodium py-
ruvate (1 mM). MCF10A cells were cultured in DMEM/F12 medium plus horse
serum (final concentration: 5% v/v), insulin (10mg/ml), epidermal growth factor
(20 ng/ml), cholera toxin (100 ng/ml), and hydrocortisone (0.5 mg/ml). IMR90
fibroblasts were cultured in Eagle’s minimum essential medium plus fetal
bovine serum (10% v/v), L-glutamine (2 mM), and nonessential amino acids
(1% v/v). HeLa S3 cells were seeded on poly-HEMA-coated plates (P3932
from Sigma, final concentration: 12 g/l). Synchronization in G2/M phase was(F) The graphs show the number of mitotic cells at 10 hpf determined by immun
(G) Cortical actin cytoskeleton was analyzed in the anterodorsal region of embryo
are shown. Red arrows mark thickening and actin protrusions on cell edges. hs-
(H) Bar graphs show the number of cell contacts (left panel) and actin protrusio
significant values (p < 0.05).
(I) Embryos were treated as in (D), with different splice-blocking morpholinos (MO
number of mitotic events (mean ± SD of two experiments) occurring from 4 to 6
Developmeperformed by D-thymidine treatment (final concentration: 2.5 mM; Sigma) for
16–18 hr followed by release in complete medium with nocodazole (final con-
centration: 200 ng/ml; Sigma). Synchronization in M phase was performed by
nocodazole treatment for 16 hr, followed by mitotic shake-off and replating on
poly-D-lysine-coated plates (final concentration: 15 mg/ml). For adhesion ex-
periments, cells were plated on fibronectin-coated coverslips (final concentra-
tion: 10 mg/ml) and monitored by immunofluorescence (FITC-phalloidin) or by
Real-Time Cell Analyzer Technology (xCELLigence Roche). Integrin activation
by Mn2+ was achieved by treating cells with MnCl2 (final concentration: 1 mM).
Y27632 was purchased from Merck (688001) and used in mitotic experiments
at a final concentration of 10 mM. DNA damage was induced by 1 hr doxoru-
bicin (final concentration: 10 mM) after 2 hr of release from D-thymidine treat-
ment. RWJ-60475 (AM)3 was purchased from Abcam (ab141729) and used at
a final concentration of 10 mM. DNA constructs expressing DEPDC1B, RhoA,
PTPRF, and GEF-H1 were transfected into Phoenix cells using calcium phos-
phate or into HeLa cells by Lipofectamine 2000. Details are reported in the
Supplemental Experimental Procedures. Custom or predesigned siRNA
oligos were used to silence endogenous expression of DEPDC1B, DEPDC1A,
vinculin, actinin, FAK, RhoA, Rac1, Cdc42, and PTPRF (see Supplemental
Experimental Procedures for siRNA sequence information). A custom nontar-
geting oligo was used as a negative control. HiPerfect Transfection Reagent
from QIAGEN was used for siRNA transfection (final oligo concentration:
50 nM), according to the manufacturer’s instructions.
Microscopy and Data Analysis
Mitotic and adhesion phenotypes were quantified by epifluorescence micro-
scopy under a fluorescent (DM5500B; Leica) microscope using a 203/NA
0.15 objective lens at room temperature. All antibodies used for immuno-
fluorescence were employed according to manufacturer’s instructions (a
complete list is reported in the Supplemental Experimental Procedures). Fluo-
rochromes used were Cy3 (cyclin B, lamin B, vinculin, pMLC2, Flag-tag),
Alexa488 (pH3), FITC-/TRITC-phalloidin, or Cy5 (vinculin [pH3], Myc-tag). All
images were acquired with a camera (DCF350FX; Leica) and LAS-AF image
software (Leica). Images were processed with the same settings (brightness,
contrast, crop, image size) using Adobe Photoshop CS5.1, and imaged figures
were constructed in Adobe Illustrator.
Confocal analysis of DEPDC1B localization, actin cytoskeleton, and FAs
was performed on a Leica TCS SP2 AOBS microscope, using a 403/NA
1.25 oil-immersion objective and processed in Adobe Photoshop. Images
were taken with identical settings, and the number and average area of FAs
per cell were determined using ImageJ software with a mask with a fixed
threshold that identifies vinculin- or paxillin-GFP positive FAs. Details on live
microscopy (time-lapse and TIRF) are in the Supplemental Experimental
Procedures.
Protein Purification and Pull-Down Experiments
pGEX-SH3BP1 (GAP domain) and pGEX-RhoA constructs were a kind gift
from Dr. Giorgio Scita (IFOM). pGEX-LAR (cytoplasmic tail) was a kind gift
from Professor Axel Ullrich (Max Planck Institute). GST-tagged proteins were
expressed in pLysS BL21 bacterial strains upon IPTG induction (0.5 mM)
and purified by glutathione sepharose beads (GE Healthcare). For GST
pull-down experiments, RhoA was further solubilized by 3C-Prescission Pro-
tease treatment. The pseudo-RhoGAP domain (aa 177–400) of DEPDC1B
was amplified by PCR using specific primers and cloned into pFastBac1-
HisMBPTEV, a custom-made vector derived from pFastBac1 (Life Technolo-
gies), expressed in High-5 insect cells with the MultiBac expression system
(Berger et al., 2004) and purified by MBP affinity followed by size exclusion
chromatography. Pull-downs with total cell lysate were performed in complete
JS buffer, whereas those with purified proteins were performed in HEPESofluorescence upon various treatments (mean ± SEM of two experiments).
s treated as in (D), at 10 hpf by FITC-phalloidin staining. Representative images
1B, human DEPDC1B mRNA. The scale bar represents 10 mm.
ns observed in two independent experiments (mean ± SEM). Asterisk marks
SBs for depdc1b, rhoab, or ptprf) at the one-cell stage. The graphs show the
hpf.
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DEPDC1B/RhoA/PTPRF Axis Controls G2/M Transition10 mM (pH 7.5), NaCl 100 mM, glycerol 5%, Tween 0.1%. Details on labeling
and quantitation of protein bound by SILAC are reported in the Supplemental
Experimental Procedures. GST-RBD assays were performed by incubating
1 mg of protein lysate with 50 mg of GST-RBD beads for 1 hr at 4C in a final
volume of 0.5 ml. Beads were washed three times with RBD Wash Buffer
(50 mM Tris-HCl [pH 7.6], 150 mM NaCl, Triton X-100 1% v/v, 10 mM MgCl2
freshly added) and resuspended in 30 ml of SDS-PAGE sample buffer.
Zebrafish Morpholinos and Time-Lapse Microscopy
A depdc1b splice-blockingmorpholinowas synthetized byGene Tools against
sequence GGTAAGAGCTGCGGGTAAAGCCTGC and used at a maximum
final concentration of 0.7 mM. rhoab ATG-morpholino was previously
described (MO1-rhoab; Zhu et al., 2008). To inhibit ptprf genes, a mixture
1:1 of ptprfa and ptprfb morpholinos was used (MO1-ptprfa and MO1-ptprfb;
Wang et al., 2012). All morpholinos were injected in one-cell stage zebrafish
embryos. Human DEPDC-1B mRNA was coinjected at a final concentration
of 50 ng/ml. The specificity of morpholinos was checked by RT-PCR on
total cDNA (details are in the Supplemental Experimental Procedures and Fig-
ure S7C). Time-lapse analysis was performed using embryos from the
Tg(h2afv:GFP)kca6 zebrafish transgenic line (Pauls et al., 2001). Embryos at
gastrula stage were embedded in a matrix of 1% low-melting agarose and
analyzed by SP2 confocal microscope using argon 488 laser. Images were
collected every 10 min with a 203 water-immersion objective. Actin cytoskel-
eton was analyzed by FITC-phalloidin (Sigma, P5282) staining (2 hr, final con-
centration: 5 mg/ml, 1% goat serum) on 10 hpf embryos fixed with 4% PFA in
PBS (overnight at 4C) and permeabilized with Triton X-100 2% for 2 hr.
Stained embryos were mounted and analyzed as above.
Statistical Analysis
Microsoft Excel was used to generate bar graphs and to perform statistical
analyses. Dot plots were produced and analyzed with Prism 6 software. Fitting
curves of mitotic time-lapse experiments were generated using JMP 10 (SAS)
software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, two tables, and two movies and can be found with this article
online at http://dx.doi.org/10.1016/j.devcel.2014.09.009.
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